Skip to main content
Oxford University Hospitals NHS Foundation Trust
Immunology Laboratory

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Basal Ganglia Antibodies

Please note: Basal Ganglia Antibody testing is performed by a referral laboratory. This assay is only available to members of Oxford University Hospitals NHS Foundation Trust.

The spectrum of disorders associated with ABGA and streptococcal infection includes Sydenham's chorea (prototype), tics (PANDAS), a subset of cases with Tourette's syndrome (TS). Rarely patients, with adult-onset tics, dystonia, and some cases with post-encephalitic Parkinsonism or encephalitis lethargica may also have ABGA. Anti-basal ganglia antibodies (ABGA) have been found with extrapyramidal movement disorders of the basal ganglia and deep grey matter with post-rheumatic fever chorea (90% sensitivity) and tics being the common manifestations, although dystonia and myoclonus have also been reported in rare incidences. A small number of patients with an encephalitic phenotype with coexistent parkinsonial features has also been reported in association with ABGA and may be described as an encephalitis-lethargica type disease. However, some patients with this EL like phenotype have been shown to have antiNMDA receptor antibodies. The sensitivity and specificity of the antibodies in post-streptococcal neurological patients is 80- 90% when compared to normal, neurological and streptococcal infection controls. False positives appear more commonly in patients with other streptococcal immune mediated manifestations such as rheumatic fever and glomerulonephritis. A small number of patients with complex cerebellar disease of unknown aetiology also have the antibodies.

This assay is performed at a referral laboratory (external users requiring Basal Ganglia Antibody testing are advised to contact the referral laboratory directly):

Neuroimmunology & CSF Laboratory (NICL)
The National Hospital for Neurology & Neurosurgery
9th Floor
Queens Square

Specimen requirements

Serum 1ml; plasma is NOT acceptable



Laboratory turnaround time

28 days

Laboratory method


Reference range/units

Negative =

Low Positive = 5-30U/ml

Associated tests


Shipping and storage

Internal hospital transport/courier.

Ensure delivery Monday to Friday 07:00 - 17:30.

Further information and contact details

For further information, email